Yarrow Bioscience, Inc. (YARW) Balance Sheet
As of 2026-06-30 (10-Q), Yarrow Bioscience, Inc. (YARW) reported total assets of $23.6M, total liabilities of $1.5M and shareholders' equity of $22.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $22.9M. Long-term debt: $0.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YARWYarrow Bioscience, Inc.Follow YARW — free
—
Price chart with a free account
- Market cap
- 51.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.0 | 10.2 | 27.9 | 43.8 | 57.6 | 42.3 | 30.9 | 30.6 | 19.9 | 24.0 | 22.9 | |
| Short-term investments | 26.9 | 49.3 | 86.7 | 16.7 | 1.0 | 0.0 | 0.0 | 62.6 | 41.6 | 5.0 | 0.0 | |
| Receivables | 0.0 | 0.8 | — | 0.1 | 15.8 | 7.6 | 0.2 | — | — | — | — | |
| Inventory | — | — | — | 1.4 | 7.4 | 7.3 | — | — | — | — | — | |
| Current assets | 31.5 | 63.9 | 139.5 | 76.4 | 87.3 | 63.2 | 38.3 | 96.0 | 64.4 | 30.0 | 23.5 | |
| Total assets | 42.1 | 66.9 | 139.9 | 81.2 | 93.7 | 67.0 | 40.8 | 97.7 | 66.9 | 30.2 | 23.6 | |
| Current liabilities | 3.9 | 7.8 | 9.5 | 29.3 | 21.8 | 18.4 | 9.3 | 7.5 | 14.8 | 2.4 | 1.5 | |
| Long-term debt | — | — | — | 32.7 | 33.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Short-term debt | — | — | — | — | 0.0 | — | — | — | — | — | — | |
| Total liabilities | 12.5 | 14.6 | 9.6 | 63.6 | 56.2 | 18.4 | 9.3 | 9.0 | 14.8 | 2.4 | 1.5 | |
| Shareholders' equity | -29.4 | 68.6 | 92.2 | 17.6 | 37.5 | 48.6 | 31.2 | 88.7 | 52.1 | 27.8 | 22.1 |
USD millions · SEC XBRL
Yarrow Bioscience, Inc. — questions
- How much cash does Yarrow Bioscience, Inc. have?
- $22.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does Yarrow Bioscience, Inc. have?
- $0 of long-term debt as of 2026-06-30.
- What are Yarrow Bioscience, Inc.'s total assets?
- $23.6M as of 2026-06-30.
- What is Yarrow Bioscience, Inc.'s shareholders' equity?
- $22.1M as of 2026-06-30.
Every figure on this page comes from Yarrow Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.